BMRN icon

BioMarin Pharmaceuticals
BMRN

Overview Fund Activity

556 hedge funds and large institutions have $13.7B invested in BioMarin Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 80 funds opening new positions, 195 increasing their positions, 193 reducing their positions, and 68 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
556
Holders Change
+4
Holders Change %
+0.72%
% of All Funds
8.8%
Holding in Top 10
6
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-25%
% of All Funds
0.09%
New
80
Increased
195
Reduced
193
Closed
68
Calls
$116M
Puts
$70.2M
Net Calls
+$45.4M
Net Calls Change
+$25.6M

Top Buyers

1
UBS Group
1
UBS Group
Switzerland
$221M
2
Viking Global Investors
2
Viking Global Investors
Connecticut
$289M
3
O
3
OrbiMed
New York
$127M
4
Citadel Advisors
4
Citadel Advisors
Florida
$161M
5
HM
5
HealthCor Management
New York
$59.3M

Top Sellers

1
Capital Research Global Investors
1
Capital Research Global Investors
California
$724M
2
ClearBridge Investments
2
ClearBridge Investments
New York
$163M
3
PA
3
Perceptive Advisors
New York
$0
4
Ameriprise
4
Ameriprise
Minnesota
$412M
5
First Trust Advisors
5
First Trust Advisors
Illinois
$46.5M
Name Holding Trade Value Shares
Change 		Shares
Change %
Northern Trust
26
Northern Trust
Illinois
$102M -$2.86M -37,047 -3%
Millennium Management
27
Millennium Management
New York
$100M +$45.8M +593,956 +84%
CCM
28
Camber Capital Management
Massachusetts
$100M +$22M +285,000 +28%
FWIA
29
Fort Washington Investment Advisors
Ohio
$95.2M +$7.05M +91,378 +8%
Bank of America
30
Bank of America
North Carolina
$93M -$35.3M -457,333 -27%
Legal & General Group
31
Legal & General Group
United Kingdom
$91.3M +$7.65M +99,255 +9%
Rockefeller Capital Management
32
Rockefeller Capital Management
New York
$87.3M -$578K -7,502 -0.7%
Charles Schwab
33
Charles Schwab
California
$87M +$2.09M +27,091 +2%
Deutsche Bank
34
Deutsche Bank
Germany
$68.7M -$3.85M -49,914 -5%
N
35
Natixis
France
$65M -$3.24M -42,084 -5%
Swiss National Bank
36
Swiss National Bank
Switzerland
$61.3M +$7.58M +98,300 +14%
HM
37
HealthCor Management
New York
$59.3M +$47M +609,696 +383%
Victory Capital Management
38
Victory Capital Management
Texas
$58M -$1.88M -23,155 -3%
Bank of New York Mellon
39
Bank of New York Mellon
New York
$57.3M +$3.1M +40,159 +6%
PHS
40
PFM Health Sciences
California
$55.4M +$19.5M +253,555 +55%
Nuveen Asset Management
41
Nuveen Asset Management
Illinois
$54.7M -$10M -123,756 -16%
Goldman Sachs
42
Goldman Sachs
New York
$54.6M -$8.21M -106,449 -13%
Jennison Associates
43
Jennison Associates
New York
$54.5M +$11.9M +153,984 +28%
D.E. Shaw & Co
44
D.E. Shaw & Co
New York
$53.1M -$18M -233,616 -25%
Morgan Stanley
45
Morgan Stanley
New York
$50.3M +$17.2M +222,564 +52%
SI
46
Scout Investments
Missouri
$50.1M +$8.84M +114,611 +21%
First Trust Advisors
47
First Trust Advisors
Illinois
$46.5M -$40.2M -521,126 -46%
Sumitomo Mitsui Trust Group
48
Sumitomo Mitsui Trust Group
Japan
$43.5M +$23.7K +308 +0.1%
EAM
49
Erste Asset Management
Austria
$43.4M -$3.6M -46,650 -8%
Dimensional Fund Advisors
50
Dimensional Fund Advisors
Texas
$42.7M +$163K +2,108 +0.4%
1
2
3 4 5